Pfizer PFE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.45B-17.7% | $17.56B+5.4% | $16.65B+13.7% | $14.65B+6.8% | $13.72B-22.8% | ||
| $3.55B-32.7% | $5.27B+26.4% | $4.17B+10.4% | $3.78B+32.8% | $2.85B-51.9% | ||
| $10.9B-11.2% | $12.29B-1.6% | $12.48B+14.8% | $10.88B0.0% | $10.87B-8.3% | ||
| 75.4%+5.5pp | 70%-5.0pp | 74.9%+0.7pp | 74.2%-5.0pp | 79.3%+12.5pp | ||
| $2.96B-28.9% | $4.16B+30.6% | $3.19B-6.7% | $3.42B+12.7% | $3.03B-29.1% | ||
| $3.17B— | —— | $3.33B+9.5% | $3.04B+9.3% | $2.79B— | ||
| $461M+23,150% | -$2M+99.1% | -$216M-253% | $141M+175% | -$189M+55.1% | ||
| $2.69B— | —— | $3.54B+21.7% | $2.91B-1.9% | $2.97B+624% | ||
| 18.6%— | —— | 21.3%+1.4pp | 19.9%-1.8pp | 21.6%+19.3pp | ||
| $0.47— | —— | $0.62+21.6% | $0.51-1.9% | $0.52+643% | ||
| $4.78B— | —— | $5B+7.0% | $4.67B+6.0% | $4.4B+146% | ||
| 33.1%— | —— | 30%-1.9pp | 31.9%-0.2pp | 32.1%+22.0pp | ||
| $3.17B— | —— | $3.33B+9.5% | $3.04B+9.3% | $2.79B— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pfizer's revenue?
- Pfizer (PFE) generated $63.3B in revenue over the trailing twelve months, up 1.4% year over year.
- Is Pfizer profitable?
- Pfizer reported $12.1B in net income over the trailing twelve months, a 15.7% net margin.
- What is Pfizer's earnings per share?
- Pfizer's diluted EPS over the trailing twelve months is $2.12.
- Where does Pfizer's income statement data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
